Heather Vital
About Heather Vital
Heather Vital VP of Development and Portfolio Strategy
Heather Vital serves as the Vice President of Development and Portfolio Strategy. She brings over 15 years of experience across various strategic and operational roles, contributing significantly to program and alliance management, portfolio planning, and research and development (R&D) strategy and commercialization. Heather's extensive background enables her to lead and execute complex projects within the pharmaceutical and biotechnology sectors.
Heather Vital Education and Expertise
Heather Vital holds a Bachelor of Science (BS) from Babson College, an MBA from the MIT Sloan School of Management, and a Master of Science (SM) from the Harvard-MIT Health Sciences and Technology Program. Her educational background equips her with a robust foundation in both business and technical aspects of healthcare and R&D, enhancing her capability to manage and strategize complex portfolios and developmental projects.
Heather Vital Background at Relay Therapeutics
At Relay Therapeutics, Heather Vital held the position of Senior Director, Portfolio Strategy and Operations. She played a crucial role in the portfolio strategies for pipeline programs and was responsible for managing alliances with a large biopharma partnership and a research collaboration. Her contributions were pivotal in driving strategic initiatives and ensuring operational efficiency within the organization.
Heather Vital Leadership Role at Deciphera Pharmaceuticals
Heather Vital served as the Senior Director of Program Leadership at Deciphera Pharmaceuticals. In this role, she was the program lead for two oncology drug programs, one of which achieved product approval. Her leadership was instrumental in guiding these programs through the various stages of development, demonstrating her expertise and commitment to advancing oncology treatments.
Heather Vital Tenure at Biogen
During her tenure at Biogen, Heather Vital held multiple roles, culminating in the position of Director, R&D Strategy and Portfolio Leadership for several disease areas. She contributed to portfolio strategy for spinal muscular atrophy, played a significant role in launching SPINRAZA as part of the global brand team, and supported new product commercialization in the immunology therapeutic area. Her work at Biogen highlighted her ability to lead strategic initiatives and bring new therapies to market.